New Hypothesis Unifies Previous Theories of Psychopathology and Identifies Core Biological Abnormality in Psychiatric Disorders

Michael Raymond Binder

doi:doi:10.11648/j.ajcem.20221001.14

| Peer-Reviewed

New Hypothesis Unifies Previous Theories of Psychopathology and Identifies Core Biological Abnormality in Psychiatric Disorders

Michael Raymond Binder

Published in American Journal of Clinical and Experimental Medicine (Volume 10, Issue 1)

Received: 4 January 2022 Accepted: 20 January 2022 Published: 28 January 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Despite millennia of philosophical debate and the enormous strides that have been made in neuroscience over the last century, the pathophysiology of psychiatric disorders remains unclear. Although the monoamine hypothesis has, for more than fifty years, provided a strong basis of support for the use of antidepressants in the treatment of depression, the overall success rate with antidepressants has been disappointingly low. Coincidingly, the monoamine hypothesis has come under increasing scrutiny for failing to explain all of the phenomena that characterize mood disorders. Consequently, mental health researchers, in an effort to find new molecular targets for treatment, have been searching for a more comprehensive explanation of the means by which psychiatric symptoms develop. Recently, several new models of depression have been proposed, including the immune, the endocrine, the glutamatergic, the GABAergic, the mitochondrial, and the neuroplastic; but none of them integrate the workings of the mind with the workings of the brain, and none of them explain how abnormalities in brain function actually translate into abnormalities in thought and emotion. However, an emerging hypothesis—one that reconceptualizes the anatomy of the cognitive-emotional system and unifies previous psychological and biological theories of psychopathology—posits that psychiatric symptoms are induced by a vicious cycle of mutual overstimulation between the mind and the brain. According to the Multi-Circuit Neuronal Hyperexcitability Hypothesis of Psychiatric Disorders, the mind, when under stress, overstimulates the associated neurons and circuits. The associated neurons and circuits, in turn, overstimulate the mind, particularly if the neurological system is inherently hyperexcitable. The result is an abnormal increase in the intensity and the duration of the associated thoughts and emotions, a change that distinguishes functionally abnormal thoughts and emotions from normal ones. A more detailed understanding of the mechanism by which psychiatric symptoms develop and perpetuate has important implications for treatment, as it would allow psychotherapists to better visualize what is happening in the cognitive-emotional system; it would allow psychiatrists to better visualize the target for medical interventions; and, by reducing the stigma of mental illness, it would allow patients to be more willing to seek and follow through with mental health care.

Published in	American Journal of Clinical and Experimental Medicine (Volume 10, Issue 1)
DOI	10.11648/j.ajcem.20221001.14
Page(s)	23-37
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Pathophysiology of Psychiatric Disorders, Biology of Mental Illness, Neuronal Hyperexcitability, Biomarkers of Disease, Objective Assessments, Anticonvulsants, Mood Stabilizers, Neuroregulators

References

[1]	Pigott HE. The STAR*D trial: It is time to reexamine the clinical beliefs that guide the treatment of major depression. Can J Psychiatry 2015; 60 (1): 9-13.
[2]	Heninger GR, Delgado PL, Charney DS. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 1996; 29 (1): 2-11.
[3]	Restak R. Mysteries of the mind. Washington, DC: National Geographic Society; 2000.
[4]	Butcher JN, Mineka S, Hooley JM, et al. Abnormal psychology, first Canadian edition. Toronto, ON: Pearson Education Canada; 2010.
[5]	Ellis A. Rational emotive behavior therapy. Corsini RJ, Wedding D, editors. Current psychotherapies. 8th ed. Belmont, CA: Thomson Brooks/Cole; 2008. p. 63-106.
[6]	Oatley K. Emotions: A brief history. Malden, MA: Blackwell Publishing; 2004.
[7]	Otte C. Cognitive behavioral therapy in anxiety disorders: Current state of the evidence. Dialogues Clin Neurosci 2011; 13: 413-421.
[8]	Jutras M. Historical perspectives on the theories, diagnosis, and treatment of mental illness 2017; 59 (2): 86-88.
[9]	Cook SC, Schwartz AC, Kaslow NJ. Evidence-based psychotherapy: Advantages and challenges. Neurotherapeutics 2017; 14 (3): 537-545.
[10]	Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000; 157 (10): 1552-1562.
[11]	Hammen C. Stress and depression. Annu Rev Clin Psychol 2005; 1: 293-319.
[12]	Amital D, Fostick L, Silberman A, Beckman M, Spivak B. Serious life events among resistant and non-resistant MDD patients. J Affect Disord 2008; 110 (3): 260-264.
[13]	Gilman SE, Trinh NH, Smoller JW, et al. Psychosocial stressors and the prognosis of major depression: a test of Axis IV. Psychol Med 2013; 43 (2): 303-316.
[14]	Monroe SM, Harkness KL. Life stress, the "kindling" hypothesis, and the recurrence of depression: considerations from a life stress perspective. Psychol Rev 2005; 112 (2): 417-445.
[15]	Harkness KL, Theriault JE, Stewart JG, Bagby RM. Acute and chronic stress exposure predicts 1-year recurrence in adult outpatients with residual depression symptoms following response to treatment. Depress Anxiety 2014; 31 (1): 1-8.
[16]	Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012; 62 (1): 63-77.
[17]	Charney DS, Menkes DB, Heninger GR. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. Arch Gen Psychiatry 1981; 38 (10): 1160-1180.
[18]	Andrade C, Rao NS. How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy. Indian J Psychiatry 2010; 52 (4): 378-386.
[19]	Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996; 17 (2): 187-205.
[20]	Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000; 23 (5): 477-501.
[21]	Liu B, Liu J, Wang M, Zhang Y, Li L. From serotonin to neuroplasticity: evolvement of theories for major depressive disorder. Front Cell Neurosci 2017; 11: 305.
[22]	Schäfers M, Sorkin L. Effect of cytokines on neuronal excitability. Neuroscience Letters 2008; 437 (3): 188-193.
[23]	Vezzani, A and Viviani, B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology 2015; 96 (Part A): 70-82.
[24]	Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Frontiers in Neuroendocrinology 2012; 33 (1): 116-125.
[25]	Allen J Romay-Tallon R, Brymer KJ, et al. Mitochondria and mood: Mitochondrial dysfunction as a key player in the manifestation of depression. Front Neurosci 2018; (12): 386.
[26]	Gold PW, Kadriu B. A major role for the lateral habenula in depressive illness: physiologic and molecular mechanisms. Front Psychiatry 2019; 10: 320.
[27]	Popovic J, Mestrovic A. Habenula – the role in depression. Gyrus 2014; 3 (2): 97-99.
[28]	Authement ME, Langlois LD, Shepard RD, et al. A role for corticotropin-releasing factor signaling in the lateral habenula and its modulation by early-life stress. Sci Signal 2018; 11 (520): 6480.
[29]	Aizawa H, Cui W, Tanaka K, Okamoto H. Hyperactivation of the habenula as a link between depression and sleep disturbance. Frontiers in Human Neuroscience 2013; 7: 1-6.
[30]	Shepard RD, Langlois LD, Browne CA, et al. Ketamine reverses lateral habenula neuronal dysfunction and behavioral immobility in the forced swim test following maternal deprivation in late adolescent rats. Front Synaptic Neurosci 2018; 10: 39.
[31]	de Kloet ER, Joëls M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005; 6 (6): 463-475.
[32]	Muller JC, Pryer WW, Gibbons JE, et al. Depression and anxiety occurring during Rauwolfia therapy. JAMA 1955; 159: 836-839.
[33]	Shore PA, Silver SL, Brodie BB. Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain. Science 1955; 122: 284-285.
[34]	Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 2000; 61 (Suppl 6): 4-6.
[35]	Neumeister A, Nugent AC, Waldeck T, et al. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry 2004; 61: 765-773.
[36]	Messay B, Lim A, Marsland AL. Current understanding of the bi-directional relationship of major depression with inflammation. Biol Mood Anxiety Disord 2012; 2: 4.
[37]	Pariante CM. Increased inflammation in depression: A little in all, or a lot in a few? Am J Psychiatry 2021; 178: 1077-1079.
[38]	Quan N, Banks WA. Brain-immune communication pathways. Brain Behav Immun. 2007; 21 (6): 727-735.
[39]	Leonard BE. The concept of depression as a dysfunction of the immune system. Cure Immunol Rev 2010; 6 (3): 205-212.
[40]	Osimo EF, Pillinger T, Rodriguez IM, et al: Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain Behav Immun 2020; 87: 901–909.
[41]	Osimo EF, Baxter LJ, Lewis G, et al: Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol Med 2019; 49: 1958–1970.
[42]	Bowcut JC, Weiser M. Inflammation and schizophrenia. Psychiatric Annals 2018; 48 (5): 237-243.
[43]	Boorman, E, Romano, GF, Russell, A, Mondelli, V, Pariante, CM. Are mood and anxiety disorders inflammatory diseases? Psychiatric Annals 2015; 45 (5): 240-248.
[44]	Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008; 358 (1): 55-68.
[45]	Hasler G. Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry 2010; 9 (3): 165-161.
[46]	Zarate CA Jr, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63 (8): 856-864.
[47]	Newport DJ, Carpenter LL, McDonald WM, et al. APA Council of Research Task Force on Novel Biomarkers and Treatments. Ketamine and other NMDA antagonists: Early clinical trials and possible mechanisms in depression. Am J Psychiatry 2015; 172 (10): 950-966.
[48]	Hasler G, van der Veen JW, Tumonis T, et al. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 2007; 64 (2): 193-200.
[49]	Hasler G, van der Veen JW, Grillon C, Drevets WC, Shen J. Effect of acute psychological stress on prefrontal GABA concentration determined by proton magnetic resonance spectroscopy. Am J Psychiatry 2010; 167 (10): 1226-1231.
[50]	Eser D, Schüle C, Baghai TC, Romeo E, Rupprecht R. Neuroactive steroids in depression and anxiety disorders: clinical studies. Neuroendocrinology 2006; 84 (4): 244-254.
[51]	Rajkowska G, O'Dwyer G, Teleki Z, Stockmeier CA, Miguel-Hidalgo JJ. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 2007; 32 (2): 471-482.
[52]	Hasler G, Neumeister A, van der Veen JW, Tumonis T, Bain EE, Shen J, Drevets WC, Charney DS. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy. Biol Psychiatry. 2005 Dec 15; 58 (12): 969-973.
[53]	Fleming KC, Volcheck MM. Central sensitization syndrome and the initial evaluation of a patient with fibromyalgia: a review. Rambam Maimonides Med J 2015; 6 (2): e0020.
[54]	Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum 2008; 37 (6): 339-352.
[55]	Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007; 36 (6): 339-356.
[56]	Fink P, Rosendal M, Dam ML, Schröder A. Ny faelles diagnose for de funktionelle sygdomme [New unifying diagnosis of functional diseases]. Ugeskr Laeger 2010; 172 (24): 1835-1838.
[57]	Carabotti M, Scirocco A, Maselli MA, Severia C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 2015; 28 (2): 203-209.
[58]	Evrensel A, Ceylan ME. The Gut-Brain Axis: The Missing Link in Depression. Clin Psychopharmacol Neurosci 2015; 13 (3): 239-244.
[59]	Mittal R, Debs LH, Liu XZ, et al. Neurotransmitters: The critical modulators regulating gut-brain axis. J Cell Physiol 2017; 232 (9): 2359-2372.
[60]	Karl JP, Hatch AM, Arcidiacono SM, et al. Effects of psychological, environmental and physical stressors on the gut microbiota. Front Microbiol 2018; 9: 2013.
[61]	Cerf M, Thiruvengadam N, Mormann F, et al. On-line, voluntary control of human temporal lobe neurons. Nature 2010; 467: 1104-1108.
[62]	Penfield W. Epilepsy and surgical therapy. Archives of Neurology and Psychiatry 1936; 36 (3): 449-484.
[63]	Al-Shargie F, Kiguchi M, Badruddin N, et al. Mental stress assessment using simultaneous measurement of EEG and fNIRS. Biomedical Optics Express 2016; 7 (10): 3882-3898.
[64]	Mazarati A, Shin D, Auvin S, Caplan R, Sankar R. Kindling epileptogenesis in immature rats leads to persistent depressive behavior. Epilepsy Behav 2007; 10: 377–383.
[65]	van der Gaag M. A neuropsychiatric model of biological and psychological processes in the remission of delusions and auditory hallucinations. Schizophr Bull 2006; 32 (Suppl 1): S113-S122.
[66]	Rose GM, Diamond DM, Pang K, Dunwiddie TV. Primed burst potentiation: lasting synaptic plasticity invoked by physiologically patterned stimulation. In: Haas HL, Buzsàki G. (eds) Synaptic plasticity in the hippocampus. Springer, Berlin, Heidelberg 1988.
[67]	Hare BD, Duman RS. Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions. Mol Psychiatry 2020; 25 (11): 2742-2758.
[68]	Tik M, Hoffmann A, Sladky R, et al. Towards understanding rTMS mechanism of action: Stimulation of the DLPFC causes network-specific increase in functional connectivity. NeuroImage 2017; 162: 289-296.
[69]	Freud S. A general introduction to psychoalaysis, trans. Joan Riviere, 1924.
[70]	Lopez-Santiago LF, Yuan Y, Wagnon JL, et al. Neuronal hyperexcitability in a mouse model of SCN8A epileptic encephalopathy. PNAS 2017; 144 (9): 2383-2388.
[71]	Ferreira MAR, O’Donovan MC, Sklar P. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008; 40 (9): 1056-1058.
[72]	Yuan A, Yi Z, Wang Q, et al. ANK3 as a risk gene for schizophrenia: new data in Han Chinese and meta analysis. Am J Med Genet B Neuropsychiatr Genet 2012; 159B (8): 997-1005.
[73]	Green EK, Grozeva D, Jones I, et al., Wellcome Trust Case Control Consortium, Holmans, PA, Owen, MJ, O'Donovan, MC, Craddock N. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 2010; 15 (10): 1016-1022.
[74]	Liu Y, Blackwood DH, Caesar S, et al. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry 2011; 16 (1).
[75]	Iqbal Z, Vandeweyer G, van der Voet M, et al. Homozygous and heterozygous disruptions of ANK3: at the crossroads of neurodevelopmental and psychiatric disorders. Human Molecular Genetics 2013; 22: 1960-1970.
[76]	Subramanian J, Dye L, Morozov, A. Rap1 signaling prevents L-type calcium channel-dependent neurotransmitter release. Journal of Neuroscience 2013; 33 (17): 7245.
[77]	Santos M, D'Amico D, Spadoni O, et al. Hippocampal hyperexcitability underlies enhanced fear memories in TgNTRK3, a panic disorder mouse model. Journal of Neuroscience 2013; 33 (38): 15259-15271.
[78]	Lopez AY, Wang X, Xu M, et al. Ankyrin-G isoform imbalance and interneuronopathy link epilepsy and bipolar disorder. Mol Psychiatry 2017; 22 (10): 1464–1472.
[79]	Contractor A, Klyachko VA, Portera-Cailliau C. Altered neuronal and circuit excitability in Fragile X syndrome. Neuron 2015; 87 (4): 699-715.
[80]	O’Brien NL, Way MJ, Kandaswamy R, et al. The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder. Psychiatric Genetics 2014; 24: 277–278.
[81]	Schizophrenia Working Group of the Psychiatric Genomics Consortium: Ripke S, Neale BM, O’Donovan MC. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511 (7510): 421-427.
[82]	Freedman R, Coon H, Myles-Worsley M, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. PNAS 1997; 94 (2): 587–592.
[83]	Binder MR. The multi-circuit neuronal hyperexcitability hypothesis of psychiatric disorders. AJCEM 2019; 7 (1): 12-30.
[84]	El-Mallakh RS, Vöhringer PA, Ostacher MM, et al. Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial. Journal of Affective Disorders 2015; 184: 318-321.
[85]	Binder MR. The neuronal excitability spectrum: A new paradigm in the diagnosis, treatment, and prevention of mental illness and its relation to chronic disease. AJCEM 2021; 9 (6): 187-203.
[86]	Henkel AW, Welzel O, Groemer T W, et al. Fluoxetine prevents stimulation-dependent fatigue of synaptic vesicle exocytosis in hippocampal neurons. Journal of Neurochemistry 2010; 114 (3): 697-705.
[87]	Lado FA and Moshé SL. (2008) How do seizures stop? Epilepsia. 49 (10): 1651-54.
[88]	Fang Y, Wang X. Ketamine for the treatment of refractory status epilepticus. Seizure 2015; 30: 14-20.
[89]	Deligiannidis KM, Meltzer-Brody S, Gunduz-Bruce H, Doherty J, Jonas J, Li S, Sankoh AJ, Silber C, Campbell AD, Werneburg B, Kanes SJ, Lasser R. Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial. JAMA Psychiatry 2021; 78 (9): 951-959.
[90]	Amann B, Grunze H, Vieta E, Trimble M. Antiepileptic drugs and mood stability. Clin EEG Neurosci 2007; 38 (2): 116-23.
[91]	Ting JT and Feng G. (2011) Neurobiology of obsessive- compulsive disorder: insights into neural circuitry dysfunction through mouse genetics. Curr Opin Neurobiol. 21 (6): 842-848.
[92]	Lindgren KA, Larson CL, Schaefer SM, et al. (1999) Thalamic metabolic rate predicts EEG alpha power in healthy control subjects but not in depressed patients. Biological Psychiatry. Vol. 45: 943-952.
[93]	Cassidy CM, Balsam PE, Weinstein JJ, et al. A perceptual inference mechanism for hallucinations linked to striatal dopamine. Current Biology 2018; 28 (4): 503-514. e4.
[94]	Gittelman JX, Perke DJ, and Portfors CV. (2013) Dopamine modulates auditory responses in the inferior colliculus in a heterogeneous manner. J Assoc Res Otolaryngol. 14 (5): 719-729.
[95]	Begh M, Beghi E, and Cornaggia CM. Epilepsy in psychiatric disorders. In: Mula M. (eds) Neuropsychiatric Symptoms of Epilepsy. Neuropsychiatric symptoms of neurological disease. pp. 289-302. Springer, Cham Publishing Company, 2016. ISBN: 978-3-319-22158-8.
[96]	Josephson CB, Lowerison M, Vallerand I, et al. Association of depression and treated depression with epilepsy and seizure outcomes: a multicohort analysis. JAMA Neurol 2017; 74 (5): 533-539.
[97]	Binder MR. Anticonvulsants: The psychotropic and medically protective drugs of the future. AJCEM 2021: 9 (5): 174-182.
[98]	Zarate C Niciu M. Ketamine for depression: evidence, challenges and promise. World Psychiatry 2015; 14 (3): 348–350.
[99]	Wada JA, Sato M, Corcoran ME. Persistent seizure susceptibility and recurrent spontaneous seizures in kindled cats. Epilepsia 1974; 15 (4): 465-478.
[100]	Binder MR. A pathophysiologically-based approach to the treatment and prevention of mental illness and its related disorders. AJCEM 2021; 9 (6): 223-232.
[101]	Cicero DC, Epler AJ, Sher KJ. Are there developmentally limited forms of bipolar disorder? J Abnorm Psychol 2009; 118 (3): 431-447.
[102]	Post RM. Mechanisms of illness progression in the recurrent affective disorders. Neurotox Res 2010; 18 (3-4): 256-271.
[103]	Burnett-Zeigler I, Schuette S, Victorson D, Wisner KL. Mind–body approaches to treating mental health symptoms among disadvantaged populations: A comprehensive review. J Altern Complement Med 2016; 22 (2): 115-124.
[104]	Johnstone T, van Reekum CM, Urry HL, Kalin NH, Davidson, RJ. Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. J. Neuroscience 2007; 27 (33): 8877-8884.
[105]	Leuchter AF, Cook IA, Hunter AM, Cai C, Horvath S. Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression. PLoS One 2012; 7 (2): 1-13. e32508.
[106]	Becker, JE, Maley, C, Shultz, E, Taylor, WD. Update on transcranial magnetic stimulation for depression and other neuropsychiatric illnesses. Psychiatric Annals 2016; 46 (11): 637-641.
[107]	Fineberg, NA, Chamberlain, SR, Goudriaan, AE, et al. New developments in human neurocognition: Clinical, genetic and brain imaging correlates of impulsivity and compulsivity. CNS Spectr 2014; 19 (1): 69–89.
[108]	Parmar A, Sarkar S. Neuroimaging studies in obsessive compulsive disorder: A narrative review. Indian Journal of Psychological Medicine 2016; 38 (5): 386-394.
[109]	Chakrabarty K, Bhattacharyya S, Christopher R, Khanna, S. Glutamatergic Dysfunction in OCD. Neuropsychopharmacology 2015; 30 (40): 1735.
[110]	Binder MR. Electrophysiology of seizure disorders may hold key to the pathophysiology of psychiatric disorders. AJCEM 2019; 7 (5): 103-110.
[111]	Hargreave E (2006). The neuroplasticity phenomenon of kindling. http://hargreaves.swong.webfactional.com/ kindle.htm. (Accessed 5/19/18).
[112]	Binder MR. FLASH syndrome: tapping into the root of chronic illness. AJCEM 2020; 8 (6): 101-109.
[113]	Ostchega Y, Porter KS, Hughes J, Dillon CF, Nwankwo T. Resting pulse rate reference data for children, adolescents, and adults: United States, 1999–2008. Division of Health and Nutrition Examination Surveys. National Health Statistics Reports 2021: 41.
[114]	Natarajan A, Su H-W, Heneghan C. Measurement of respiratory rate using wearable devices and applications to COVID-19 detection. npj Digital Medicine 2021; 136.
[115]	Kannel WB, Wilson P, Blair SN. Epidemiologic assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J 1985; 109: 876–885.
[116]	Binder MR. Introducing the term “Neuroregulator” in psychiatry. AJCEM 2019; 7 (3): 66-70.
[117]	Binder MR. Gabapentin—the popular but controversial anticonvulsant drug may be zeroing in on the pathophysiology of disease. AJCEM 2021; 9 (4): 122-134.

Cite This Article

Plain Text BibTeX RIS

APA Style

Michael Raymond Binder. (2022). New Hypothesis Unifies Previous Theories of Psychopathology and Identifies Core Biological Abnormality in Psychiatric Disorders. American Journal of Clinical and Experimental Medicine, 10(1), 23-37. https://doi.org/10.11648/j.ajcem.20221001.14

Copy | Download

ACS Style

Michael Raymond Binder. New Hypothesis Unifies Previous Theories of Psychopathology and Identifies Core Biological Abnormality in Psychiatric Disorders. Am. J. Clin. Exp. Med. 2022, 10(1), 23-37. doi: 10.11648/j.ajcem.20221001.14

Copy | Download

AMA Style

Michael Raymond Binder. New Hypothesis Unifies Previous Theories of Psychopathology and Identifies Core Biological Abnormality in Psychiatric Disorders. Am J Clin Exp Med. 2022;10(1):23-37. doi: 10.11648/j.ajcem.20221001.14

Copy | Download

@article{10.11648/j.ajcem.20221001.14,
  author = {Michael Raymond Binder},
  title = {New Hypothesis Unifies Previous Theories of Psychopathology and Identifies Core Biological Abnormality in Psychiatric Disorders},
  journal = {American Journal of Clinical and Experimental Medicine},
  volume = {10},
  number = {1},
  pages = {23-37},
  doi = {10.11648/j.ajcem.20221001.14},
  url = {https://doi.org/10.11648/j.ajcem.20221001.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajcem.20221001.14},
  abstract = {Despite millennia of philosophical debate and the enormous strides that have been made in neuroscience over the last century, the pathophysiology of psychiatric disorders remains unclear. Although the monoamine hypothesis has, for more than fifty years, provided a strong basis of support for the use of antidepressants in the treatment of depression, the overall success rate with antidepressants has been disappointingly low. Coincidingly, the monoamine hypothesis has come under increasing scrutiny for failing to explain all of the phenomena that characterize mood disorders. Consequently, mental health researchers, in an effort to find new molecular targets for treatment, have been searching for a more comprehensive explanation of the means by which psychiatric symptoms develop. Recently, several new models of depression have been proposed, including the immune, the endocrine, the glutamatergic, the GABAergic, the mitochondrial, and the neuroplastic; but none of them integrate the workings of the mind with the workings of the brain, and none of them explain how abnormalities in brain function actually translate into abnormalities in thought and emotion. However, an emerging hypothesis—one that reconceptualizes the anatomy of the cognitive-emotional system and unifies previous psychological and biological theories of psychopathology—posits that psychiatric symptoms are induced by a vicious cycle of mutual overstimulation between the mind and the brain. According to the Multi-Circuit Neuronal Hyperexcitability Hypothesis of Psychiatric Disorders, the mind, when under stress, overstimulates the associated neurons and circuits. The associated neurons and circuits, in turn, overstimulate the mind, particularly if the neurological system is inherently hyperexcitable. The result is an abnormal increase in the intensity and the duration of the associated thoughts and emotions, a change that distinguishes functionally abnormal thoughts and emotions from normal ones. A more detailed understanding of the mechanism by which psychiatric symptoms develop and perpetuate has important implications for treatment, as it would allow psychotherapists to better visualize what is happening in the cognitive-emotional system; it would allow psychiatrists to better visualize the target for medical interventions; and, by reducing the stigma of mental illness, it would allow patients to be more willing to seek and follow through with mental health care.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - New Hypothesis Unifies Previous Theories of Psychopathology and Identifies Core Biological Abnormality in Psychiatric Disorders
AU  - Michael Raymond Binder
Y1  - 2022/01/28
PY  - 2022
N1  - https://doi.org/10.11648/j.ajcem.20221001.14
DO  - 10.11648/j.ajcem.20221001.14
T2  - American Journal of Clinical and Experimental Medicine
JF  - American Journal of Clinical and Experimental Medicine
JO  - American Journal of Clinical and Experimental Medicine
SP  - 23
EP  - 37
PB  - Science Publishing Group
SN  - 2330-8133
UR  - https://doi.org/10.11648/j.ajcem.20221001.14
AB  - Despite millennia of philosophical debate and the enormous strides that have been made in neuroscience over the last century, the pathophysiology of psychiatric disorders remains unclear. Although the monoamine hypothesis has, for more than fifty years, provided a strong basis of support for the use of antidepressants in the treatment of depression, the overall success rate with antidepressants has been disappointingly low. Coincidingly, the monoamine hypothesis has come under increasing scrutiny for failing to explain all of the phenomena that characterize mood disorders. Consequently, mental health researchers, in an effort to find new molecular targets for treatment, have been searching for a more comprehensive explanation of the means by which psychiatric symptoms develop. Recently, several new models of depression have been proposed, including the immune, the endocrine, the glutamatergic, the GABAergic, the mitochondrial, and the neuroplastic; but none of them integrate the workings of the mind with the workings of the brain, and none of them explain how abnormalities in brain function actually translate into abnormalities in thought and emotion. However, an emerging hypothesis—one that reconceptualizes the anatomy of the cognitive-emotional system and unifies previous psychological and biological theories of psychopathology—posits that psychiatric symptoms are induced by a vicious cycle of mutual overstimulation between the mind and the brain. According to the Multi-Circuit Neuronal Hyperexcitability Hypothesis of Psychiatric Disorders, the mind, when under stress, overstimulates the associated neurons and circuits. The associated neurons and circuits, in turn, overstimulate the mind, particularly if the neurological system is inherently hyperexcitable. The result is an abnormal increase in the intensity and the duration of the associated thoughts and emotions, a change that distinguishes functionally abnormal thoughts and emotions from normal ones. A more detailed understanding of the mechanism by which psychiatric symptoms develop and perpetuate has important implications for treatment, as it would allow psychotherapists to better visualize what is happening in the cognitive-emotional system; it would allow psychiatrists to better visualize the target for medical interventions; and, by reducing the stigma of mental illness, it would allow patients to be more willing to seek and follow through with mental health care.
VL  - 10
IS  - 1
ER  -

Copy | Download

Author Information

Michael Raymond Binder

NorthShore University HealthSystem, Highland Park Hospital, Highland Park, USA

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Michael Raymond Binder. (2022). New Hypothesis Unifies Previous Theories of Psychopathology and Identifies Core Biological Abnormality in Psychiatric Disorders. American Journal of Clinical and Experimental Medicine, 10(1), 23-37. https://doi.org/10.11648/j.ajcem.20221001.14

Copy | Download

ACS Style

Michael Raymond Binder. New Hypothesis Unifies Previous Theories of Psychopathology and Identifies Core Biological Abnormality in Psychiatric Disorders. Am. J. Clin. Exp. Med. 2022, 10(1), 23-37. doi: 10.11648/j.ajcem.20221001.14

Copy | Download

AMA Style

Michael Raymond Binder. New Hypothesis Unifies Previous Theories of Psychopathology and Identifies Core Biological Abnormality in Psychiatric Disorders. Am J Clin Exp Med. 2022;10(1):23-37. doi: 10.11648/j.ajcem.20221001.14

Copy | Download

@article{10.11648/j.ajcem.20221001.14,
  author = {Michael Raymond Binder},
  title = {New Hypothesis Unifies Previous Theories of Psychopathology and Identifies Core Biological Abnormality in Psychiatric Disorders},
  journal = {American Journal of Clinical and Experimental Medicine},
  volume = {10},
  number = {1},
  pages = {23-37},
  doi = {10.11648/j.ajcem.20221001.14},
  url = {https://doi.org/10.11648/j.ajcem.20221001.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajcem.20221001.14},
  abstract = {Despite millennia of philosophical debate and the enormous strides that have been made in neuroscience over the last century, the pathophysiology of psychiatric disorders remains unclear. Although the monoamine hypothesis has, for more than fifty years, provided a strong basis of support for the use of antidepressants in the treatment of depression, the overall success rate with antidepressants has been disappointingly low. Coincidingly, the monoamine hypothesis has come under increasing scrutiny for failing to explain all of the phenomena that characterize mood disorders. Consequently, mental health researchers, in an effort to find new molecular targets for treatment, have been searching for a more comprehensive explanation of the means by which psychiatric symptoms develop. Recently, several new models of depression have been proposed, including the immune, the endocrine, the glutamatergic, the GABAergic, the mitochondrial, and the neuroplastic; but none of them integrate the workings of the mind with the workings of the brain, and none of them explain how abnormalities in brain function actually translate into abnormalities in thought and emotion. However, an emerging hypothesis—one that reconceptualizes the anatomy of the cognitive-emotional system and unifies previous psychological and biological theories of psychopathology—posits that psychiatric symptoms are induced by a vicious cycle of mutual overstimulation between the mind and the brain. According to the Multi-Circuit Neuronal Hyperexcitability Hypothesis of Psychiatric Disorders, the mind, when under stress, overstimulates the associated neurons and circuits. The associated neurons and circuits, in turn, overstimulate the mind, particularly if the neurological system is inherently hyperexcitable. The result is an abnormal increase in the intensity and the duration of the associated thoughts and emotions, a change that distinguishes functionally abnormal thoughts and emotions from normal ones. A more detailed understanding of the mechanism by which psychiatric symptoms develop and perpetuate has important implications for treatment, as it would allow psychotherapists to better visualize what is happening in the cognitive-emotional system; it would allow psychiatrists to better visualize the target for medical interventions; and, by reducing the stigma of mental illness, it would allow patients to be more willing to seek and follow through with mental health care.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - New Hypothesis Unifies Previous Theories of Psychopathology and Identifies Core Biological Abnormality in Psychiatric Disorders
AU  - Michael Raymond Binder
Y1  - 2022/01/28
PY  - 2022
N1  - https://doi.org/10.11648/j.ajcem.20221001.14
DO  - 10.11648/j.ajcem.20221001.14
T2  - American Journal of Clinical and Experimental Medicine
JF  - American Journal of Clinical and Experimental Medicine
JO  - American Journal of Clinical and Experimental Medicine
SP  - 23
EP  - 37
PB  - Science Publishing Group
SN  - 2330-8133
UR  - https://doi.org/10.11648/j.ajcem.20221001.14
AB  - Despite millennia of philosophical debate and the enormous strides that have been made in neuroscience over the last century, the pathophysiology of psychiatric disorders remains unclear. Although the monoamine hypothesis has, for more than fifty years, provided a strong basis of support for the use of antidepressants in the treatment of depression, the overall success rate with antidepressants has been disappointingly low. Coincidingly, the monoamine hypothesis has come under increasing scrutiny for failing to explain all of the phenomena that characterize mood disorders. Consequently, mental health researchers, in an effort to find new molecular targets for treatment, have been searching for a more comprehensive explanation of the means by which psychiatric symptoms develop. Recently, several new models of depression have been proposed, including the immune, the endocrine, the glutamatergic, the GABAergic, the mitochondrial, and the neuroplastic; but none of them integrate the workings of the mind with the workings of the brain, and none of them explain how abnormalities in brain function actually translate into abnormalities in thought and emotion. However, an emerging hypothesis—one that reconceptualizes the anatomy of the cognitive-emotional system and unifies previous psychological and biological theories of psychopathology—posits that psychiatric symptoms are induced by a vicious cycle of mutual overstimulation between the mind and the brain. According to the Multi-Circuit Neuronal Hyperexcitability Hypothesis of Psychiatric Disorders, the mind, when under stress, overstimulates the associated neurons and circuits. The associated neurons and circuits, in turn, overstimulate the mind, particularly if the neurological system is inherently hyperexcitable. The result is an abnormal increase in the intensity and the duration of the associated thoughts and emotions, a change that distinguishes functionally abnormal thoughts and emotions from normal ones. A more detailed understanding of the mechanism by which psychiatric symptoms develop and perpetuate has important implications for treatment, as it would allow psychotherapists to better visualize what is happening in the cognitive-emotional system; it would allow psychiatrists to better visualize the target for medical interventions; and, by reducing the stigma of mental illness, it would allow patients to be more willing to seek and follow through with mental health care.
VL  - 10
IS  - 1
ER  -

Copy | Download